comparemela.com

Page 5 - Burney Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teladoc Health (NYSE:TDOC) Reaches New 52-Week Low at $10 93

Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as $10.93 and last traded at $11.08, with a volume of 4487893 shares. The stock had previously closed at $11.24. Analysts Set New Price Targets Several analysts recently weighed in on TDOC shares. […]

Teladoc Health (NYSE:TDOC) Reaches New 52-Week Low at $10 93

Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as $10.93 and last traded at $11.08, with a volume of 4487893 shares. The stock had previously closed at $11.24. Analysts Set New Price Targets Several analysts recently weighed in on TDOC shares. […]

Crestline Management LP Invests $2 97 Million in American Financial Group, Inc (NYSE:AFG)

Crestline Management LP acquired a new stake in American Financial Group, Inc. (NYSE:AFG – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 25,000 shares of the insurance provider’s stock, valued at approximately $2,972,000. Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Qsemble Capital […]

Affiliated Managers Group, Inc (NYSE:AMG) Expected to Post Q4 2024 Earnings of $6 93 Per Share

Affiliated Managers Group, Inc. (NYSE:AMG – Free Report) – Stock analysts at Zacks Research upped their Q4 2024 EPS estimates for shares of Affiliated Managers Group in a report issued on Monday, May 27th. Zacks Research analyst R. Department now forecasts that the asset manager will post earnings per share of $6.93 for the quarter, […]

PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $32 00

PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price objective lifted by The Goldman Sachs Group from $18.00 to $32.00 in a report published on Tuesday, Benzinga reports. The Goldman Sachs Group currently has a sell rating on the biopharmaceutical company’s stock. Several other analysts also recently commented on the stock. Citigroup raised their target […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.